BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4128407)

  • 1. Immunological tolerance to Erwinia carotovora L-asparaginase.
    Ashworth LA; Maclennan AP
    Int Arch Allergy Appl Immunol; 1973; 45(6):915-29. PubMed ID: 4128407
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the L-asparaginases from Escherichia coli and Erwinia carotovora as immunosuppressants.
    Ashworth LA; MacLennan AP
    Cancer Res; 1974 Jun; 34(6):1353-9. PubMed ID: 4596965
    [No Abstract]   [Full Text] [Related]  

  • 3. Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli.
    Ohnuma T; Holland JF; Meyer P
    Cancer; 1972 Aug; 30(2):376-81. PubMed ID: 4559405
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase.
    Uren JR; Hargis BJ; Beardsley P
    Cancer Res; 1982 Oct; 42(10):4068-71. PubMed ID: 7105004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE ROLE OF ANTIGEN DOSAGE IN DRUG-INDUCED IMMUNOLOGIC TOLERANCE.
    SCHWARTZ RS; DAMESHEK W
    J Immunol; 1963 May; 90():703-10. PubMed ID: 14053288
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide-induced tolerance to equine globulin and to equine-anti-mouse-thymocyte globulin in adult mice. I. Studies on antigen and drug requirements.
    Stockman GD; Trentin JJ
    J Immunol; 1972 Jan; 108(1):112-8. PubMed ID: 4110794
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative experimental evaluation of immunodepressive and toxic effects of L-asparaginase (NSC-109229) from Escherichia coli and from Erwinia carotovora.
    Cavanna M; Celle G; Dodero M; Picciotto A; Pannacciulli I; Brambilla G
    Cancer Treat Rep; 1976 Mar; 60(3):255-7. PubMed ID: 769978
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of an experimental study of the antitumor activity of 1-asparaginase from E. coli and Erw. carotovora].
    Terent'eva TG; Sokolov AB; Navashin SM
    Antibiotiki; 1977 Jan; 22(1):78-81. PubMed ID: 320935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in the therapeutic, immunological, and clearance properties of Escherichia coli and Erwinia carotovora L-asparaginases by attachment of poly-DL-alanyl peptides.
    Uren JR; Ragin RC
    Cancer Res; 1979 Jun; 39(6 Pt 1):1927-33. PubMed ID: 376113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on the prevention of tolerance induction by poly A:U.
    Capanna SL; Kong YM
    Immunology; 1974 Oct; 27(4):647-53. PubMed ID: 4140149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
    Ridgway D; Neerhout RC; Bleyer A
    Cancer; 1989 Feb; 63(3):561-3. PubMed ID: 2643458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic and immunodepressive effects of L-asparaginase from E. coli and from Erwinia carotovora following chronic administration in rats.
    Celle G; Dodero M; Cuneo P; Picciotto A; Brambilla G; Cavanna M; Pannaciulli I
    Arzneimittelforschung; 1977; 27(11):2046-50. PubMed ID: 341899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction of immunologic tolerance against L-asparaginase from E. coli].
    Hopf U; Land W; Furthmayr H; Timpl R; Brendel W
    Klin Wochenschr; 1971 Jun; 49(12):711-3. PubMed ID: 4996693
    [No Abstract]   [Full Text] [Related]  

  • 14. Variation in the occurrence of extracellular diffusible antigens in temperature-induced variants of Erwinia herbicola Y46, and observations of their relationships with Erwinia amylovora.
    Gibbins LN
    Can J Microbiol; 1974 May; 20(5):643-8. PubMed ID: 4208906
    [No Abstract]   [Full Text] [Related]  

  • 15. Cells involved in the immune response. IV. The response of normal and immune rabbit bone marrow and lymphoid tissue lymphocytes to antigens in vitro.
    Singhal SK; Richter M
    J Exp Med; 1968 Nov; 128(5):1099-128. PubMed ID: 4176224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of L-asparaginase from Erwinia carotovora using human serum albumin.
    Nerkar DP; Gangadharan M
    Mol Biother; 1989; 1(3):152-4. PubMed ID: 2604913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the induction of immunological paralysis to bovine gamma-globulin in adult mice. II. The effect of cyclophosphamide.
    Kawaguchi S
    Immunology; 1970 Aug; 19(2):291-9. PubMed ID: 4097111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Erwinia asparaginase antibodies during treatment of childhood acute lymphoblastic leukemia and their relationship to outcome: a case-control study.
    Klug Albertsen B; Schmiegelow K; Schrøder H; Carlsen NT; Rosthøj S; Avramis VI; Jakobsen P
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):117-20. PubMed ID: 12172975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of the electronic and steric environments of tyrosyl residues in ribonuclease A and Erwinia carotovora L-asparaginase through fluorescence quenching by caesium, iodide and phosphate ions.
    Homer RB; Allsopp SR
    Biochim Biophys Acta; 1976 Jun; 434(2):297-310. PubMed ID: 986170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appendix and gamma M-antibody formation. I. Immune response and tolerance to bovine gamma globulin in irradiated, appendix-shielded rabbits.
    Hanaoka M; Nomoto K; Waksman BH
    J Immunol; 1970 Mar; 104(3):616-25. PubMed ID: 4190968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.